{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:46:35Z","timestamp":1774269995221,"version":"3.50.1"},"reference-count":29,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s401533","type":"journal-article","created":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T04:55:09Z","timestamp":1679115309000},"page":"1573-1578","source":"Crossref","is-referenced-by-count":11,"title":["Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-5767","authenticated-orcid":true,"given":"Pengzhi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.GPP3-0053-2018","volume":"7","author":"Fiore","year":"2019","journal-title":"Microbiol Spectr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12879-020-4892-4","volume":"20","author":"Li","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s15010-007-7123-7","volume":"37","author":"Grupper","year":"2009","journal-title":"Infection"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.11150\/kansenshogakuzasshi.85.380","volume":"85","author":"Kimura","year":"2011","journal-title":"Kansenshogaku Zasshi"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13756-020-00770-1","volume":"9","author":"Zhou","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.12669\/pjms.293.2925","volume":"29","author":"Bi","year":"2013","journal-title":"Pak J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/s0163-4453(09)60009-8","volume":"59","author":"Vinh","year":"2009","journal-title":"J Infect"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s40265-021-01576-0","volume":"81","author":"Hoy","year":"2021","journal-title":"Drugs"},{"key":"ref9","unstructured":"MicuRx Pharmaceuticals, Inc. MicuRx reports positive top-line results of a China Phase 3 clinical trial for novel antibiotic contezolid in complicated skin and soft tissue infections. MicuRx Pharmaceuticals; 2019."},{"key":"ref10","volume-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection","year":"2014"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2147\/idr.S358248","volume":"15","author":"Alduhaidhawi","year":"2022","journal-title":"Infect Drug Resist"},{"key":"ref12","first-page":"768","volume":"68","author":"Raza","year":"2018","journal-title":"J Pak Med Assoc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-199507000-00003","volume":"74","author":"Patterson","year":"1995","journal-title":"Medicine"},{"key":"ref14","volume-title":"StatPearls","year":"2022"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/milmed\/usaa229","volume":"186","author":"Stagliano","year":"2021","journal-title":"Mil Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4314\/ajid.v5i2.66513","volume":"5","author":"Olawale","year":"2011","journal-title":"Afr J Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/157489112799829774","volume":"7","author":"Savini","year":"2012","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1378\/chest.65.6.688","volume":"65","author":"Morris","year":"1974","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1258\/ijsa.2008.008456","volume":"20","author":"Vanschooneveld","year":"2009","journal-title":"Int J STD AIDS"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1432-2277.2006.00403.x","volume":"20","author":"Levora","year":"2007","journal-title":"Transpl Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2147\/cia.S133640","volume":"13","author":"Giarratano","year":"2018","journal-title":"Clin Interv Aging"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cmi.2014.08.018","volume":"21","author":"Beckett","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/jpp.JPP_167_16","volume":"8","author":"Nishijo","year":"2017","journal-title":"J Pharmacol Pharmacother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1248\/bpb.b16-00427","volume":"39","author":"Tajima","year":"2016","journal-title":"Biol Pharm Bull"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1124\/dmd.114.061747","volume":"43","author":"Meng","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/jac\/dkac073","volume":"77","author":"Zhao","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"729900","DOI":"10.3389\/fmicb.2021.729900","volume":"12","author":"Wang","year":"2021","journal-title":"Front Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.2147\/idr.S373082","volume":"15","author":"Kang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.00493-18","volume":"62","author":"Shoen","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=88272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=88272","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T04:55:13Z","timestamp":1679115313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/sequential-therapy-of-linezolid-and-contezolid-to-treat-vancomycin-res-peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"URL":"https:\/\/doi.org\/10.2147\/idr.s401533","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}